NeuBase Announces Formation of Gene Editing Advisory Board

16.05.2023 - Appointed Jeffrey Kindler, J.D. and John Maraganore, Ph.D. as strategy and business advisors to the CompanyPITTSBURGH, May 16, 2023 (GLOBE NEWSWIRE) - NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company ... Seite 1

Related Keywords

John Maraganore ,Jeffrey Kindler ,Dietricha Stephan ,Company Patr ,Neubase Therapeutics Inc ,American Society Of Gene Cell Therapy ,Nasdaq ,Appointed Jeffrey Kindler ,Base Therapeutics ,Stealth Editors ,Chief Executive Officer ,American Society ,Cell Therapy ,Annual Meeting ,Neubase Therapeutics ,